Cargando…
Circulating exosomal mRNA signatures for the early diagnosis of clear cell renal cell carcinoma
BACKGROUND: There are no proven tumor biomarkers for the early diagnosis of clear cell renal cell carcinoma (ccRCC) thus far. This study aimed to identify novel biomarkers of ccRCC based on exosomal mRNA (emRNA) profiling and develop emRNA-based signatures for the early detection of ccRCC. METHODS:...
Autores principales: | He, Xing, Tian, Feng, Guo, Fei, Zhang, Fangxing, Zhang, Huiyong, Ji, Jin, Zhao, Lin, He, Jingyi, Xiao, Yutian, Li, Longman, Wei, Chunmeng, Huang, Caihong, Li, Yexin, Zhang, Feng, Yang, Bo, Ye, Huamao, Wang, Fubo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404613/ https://www.ncbi.nlm.nih.gov/pubmed/36002886 http://dx.doi.org/10.1186/s12916-022-02467-1 |
Ejemplares similares
-
Circulating exosomal mRNA profiling identifies novel signatures for the detection of prostate cancer
por: Ji, Jin, et al.
Publicado: (2021) -
Establishment of a risk score model for bladder urothelial carcinoma based on energy metabolism‐related genes and their relationships with immune infiltration
por: Huang, Caihong, et al.
Publicado: (2023) -
Circulating Exosomal microRNAs as Biomarkers of Systemic Lupus Erythematosus
por: Li, Wengen, et al.
Publicado: (2020) -
Tumor-derived exosomes facilitate tumor cells escape from drug therapy in clear cell renal cell carcinoma
por: Wang, Xiaogang, et al.
Publicado: (2020) -
Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer
por: Jia, Shiyu, et al.
Publicado: (2017)